Mangalam Drugs and Organics Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 57.35 | 73.25 | 88.84 |
Operating Expense | 61.85 | 62.88 | 79.94 |
Net Profit | -13.73 | 0.15 | 1.40 |
Net Profit Margin | -23.94 | 0.20 | 1.58 |
Earning Per Share | -8.67 | 0.10 | 0.89 |
EBIDTA | -5.31 | 8.86 | 8.82 |
Effective Tax Rate | TBA | 0.68 | TBA |
Particulars | Jun 2025 |
---|---|
Revenue | 57.35 |
Operating Expense | 61.85 |
Net Profit | -13.73 |
Net Profit Margin | -23.94 |
Earning Per Share | -8.67 |
EBIDTA | -5.31 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 318.23 | 368.59 | 372.25 |
Operating Expenses Annual | 282.43 | 351.22 | 346.53 |
Operating Profit Annual | 36.30 | 17.49 | 26.16 |
Interest Annual | 14.93 | 13.92 | 12.96 |
Depreciation | 16.38 | 14.63 | 10.99 |
Net Profit Annual | 6.92 | -9.05 | 1.27 |
Tax Annual | -1.93 | -2.01 | 0.94 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 318.23 |
Operating Expenses Annual | 282.43 |
Operating Profit Annual | 36.30 |
Interest Annual | 14.93 |
Depreciation | 16.38 |
Net Profit Annual | 6.92 |
Tax Annual | -1.93 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 1 | 1.04 | 1.95 |
Cash Flow from Operations | 42.76 | 12.17 | 38.08 |
Cash Flow from Investing | -19.47 | -17.90 | -22.17 |
Cash Flow from Financing | -21.71 | 5.70 | -16.82 |
Cash Flow at the End | 2.57 | 1 | 1.04 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 1 |
Cash Flow from Operations | 42.76 |
Cash Flow from Investing | -19.47 |
Cash Flow from Financing | -21.71 |
Cash Flow at the End | 2.57 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | 11.41 | 4.75 | 7.03 |
PBIT Margin (%) | 6.26 | 0.78 | 4.08 |
PBT Margin (%) | 5.84 | 0.72 | 3.77 |
Net PROFIT Margin (%) | 2.17 | -2.46 | 0.34 |
Return On Networth / Equity (%) | 4.76 | -6.15 | 0.84 |
Return On Networth /Employed (%) | 7.94 | 1.15 | 6.25 |
Return On Assets (%) | 2.76 | -3.66 | 0.52 |
Total Debt / Equity (X) | 0.70 | 0.66 | 0.58 |
Asset Turnover Ratio (%) | 1.27 | 1.49 | 1.53 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | 11.41 |
PBIT Margin (%) | 6.26 |
PBT Margin (%) | 5.84 |
Net PROFIT Margin (%) | 2.17 |
Return On Networth / Equity (%) | 4.76 |
Return On Networth /Employed (%) | 7.94 |
Return On Assets (%) | 2.76 |
Total Debt / Equity (X) | 0.70 |
Asset Turnover Ratio (%) | 1.27 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 158.21 | 155.04 | 151.85 |
Total Current Assets Annual | 198.99 | 199.78 | 203.26 |
Non Current Assets Annual | 160.25 | 157.36 | 154.72 |
Total Shareholders Funds Annual | 148.66 | 142.35 | 151.96 |
Total Assets Annual | 359.24 | 357.14 | 357.98 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 158.21 |
Total Current Assets Annual | 198.99 |
Non Current Assets Annual | 160.25 |
Total Shareholders Funds Annual | 148.66 |
Total Assets Annual | 359.24 |
EPS (INR)
Expected
0.00
Reported
-8.72
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%